Evaluating STI screening and antimicrobial resistance in Neisseria gonorrhoeae among PrEP users in Vietnam
评估越南 PrEP 使用者中性传播感染筛查和淋病奈瑟菌耐药性
基本信息
- 批准号:10343849
- 负责人:
- 金额:$ 16.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-05 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAffectAnatomyAntibiotic susceptibilityAntibioticsAntimicrobial ResistanceAntimicrobial susceptibilityAzithromycinCephalosporinsCharacteristicsChlamydia trachomatisCiprofloxacinDataDevelopmentDiagnosticDiagnostic testsElementsEpidemicFoundationsFrequenciesFutureGeneral PopulationGenesGeneticGenetic MarkersGenitourinary systemGenomicsGuidelinesHIVHIV InfectionsHIV riskHealthIncidenceIndividualInfectionKnowledgeLocal GovernmentManuscriptsMedicalMeta-AnalysisModelingMultiple Anatomic SitesNeisseriaNeisseria gonorrhoeaeOropharyngealPenicillin ResistancePhasePredispositionPregnant WomenPrevalencePublishingRapid screeningReportingResearch PersonnelResistanceRiskRisk FactorsSexually Transmitted DiseasesSiteSyphilisTest ResultTestingTrainingUnited NationsUniversitiesVietnamWorkWorld Health Organizationacceptability and feasibilitycohortdata sharingdrug-resistant gonorrheagenome sequencinggenomic locusglobal healthglobal health emergencyhigh risk meninsightlow and middle-income countriesmen who have sex with menpre-exposure prophylaxisprogramsrectalresistant strainroutine screeningsatisfactionscreeningtooltransgender womentransmission processwhole genomewillingness to pay
项目摘要
PROJECT ABSTRACT
Men who have sex with men (MSM) are at higher risk for HIV and sexually transmitted infections (STIs)
that increase HIV risk, such as Neisseria gonorrhoeae and Chlamydia trachomatis. HIV pre-exposure
prophylaxis (PrEP) users—many of whom are MSM—are also at increased risk for STIs. U.S. guidelines
recommend that PrEP users undergo frequent screening in multiple anatomic sites (pharyngeal, urogenital,
and rectal) for asymptomatic infections. However, lower- and middle-income countries (LMICs) lack such
guidelines, resulting in missed opportunities for STI screening and treatment among LMIC PrEP users.
Antimicrobial resistance (AMR) in N. gonorrhoeae is an urgent global health threat and the prevalence is
highest in LMICs, where access to diagnostics is limited. In particular, the Western Pacific Region, which
includes the LMIC of Vietnam, has seen increasing spread of AMR in N. gonorrhoeae, which has spread
worldwide. Major gaps exist in understanding the drivers of AMR in N. gonorrhoeae in LMICs.
In this study, investigators from UCLA and Hanoi Medical University will investigate the acceptability and
feasibility of C. trachomatis and N. gonorrhoeae screening among MSM and transwomen engaged in an HIV
PrEP program in Hanoi, Vietnam. We hypothesize that screening will be acceptable and feasible. We will also
investigate risk factors for AMR and genomic relationships between commensal Neisseria and N. gonorrhoeae
at genetic loci associated with AMR, hypothesizing that recent antibiotic use is a risk factor for AMR.
AIM 1: (a) To determine the distribution of anorectal, pharyngeal, and urogenital C. trachomatis and N.
gonorrhoeae infections among MSM and transgender women PrEP users (n=1,300) in Hanoi, Vietnam and (b)
To evaluate the acceptability and feasibility, including willingness to pay, of rapid, triple-site testing.
AIM 2: (a) To collect, culture, and perform antibiotic susceptibility testing on N. gonorrhoeae and oropharyngeal
Neisseria species to investigate the prevalence and correlates of AMR and b) To perform whole-genome
sequencing on pairs of N. gonorrhoeae and Neisseria species isolated from within the same individual to
investigate relationships within genes associated with antimicrobial resistance in N. gonorrhoeae.
This two-year project has four phases. Phase 1 will last three months and will involve development of study
materials, planning, and training. Phase 2 will last one year and will evaluate acceptability and feasibility of C.
trachomatis and N. gonorrhoeae screening. Phase 3 will last 9 months and will involve antimicrobial
susceptibility testing and whole genome sequencing. Phase 4 will last 3 months and will involve dissemination
of findings through manuscripts, presentations, and sharing of data with local government and health agencies.
Findings from the study will form the foundation for a future R01-proposal to investigate the impact of routine
screening and treatment of STIs on the development of antimicrobial resistance is N. gonorrhoeae.
项目摘要
男男性行为者 (MSM) 感染艾滋病毒和性传播感染 (STI) 的风险较高
增加艾滋病毒风险的因素,例如淋病奈瑟菌和沙眼衣原体。
美国指南指出,预防 (PrEP) 使用者(其中许多是 MSM)感染性传播感染的风险也较高。
建议 PrEP 用户在多个解剖部位(咽、泌尿生殖、
然而,低收入和中等收入国家(LMIC)缺乏此类感染。
指南,导致中低收入国家 PrEP 用户错过性传播感染筛查和治疗的机会。
淋病奈瑟菌的抗生素耐药性 (AMR) 是一个紧迫的全球健康威胁,其患病率很高
中低收入国家的情况最为严重,因为这些国家获得诊断的机会有限,特别是西太平洋区域。
包括越南的中低收入国家,淋病奈瑟菌中的抗菌素耐药性不断增加,而淋病奈瑟菌已在其中传播
在了解中低收入国家淋病奈瑟菌抗菌素耐药性的驱动因素方面存在重大差距。
在这项研究中,加州大学洛杉矶分校和河内医科大学的研究人员将调查其可接受性和
在 MSM 和感染 HIV 的跨性别女性中进行沙眼衣原体和淋病奈瑟菌筛查的可行性
我们勇敢地说,越南河内的 PrEP 计划是可以接受和可行的。
研究共生奈瑟菌和淋病奈瑟菌之间 AMR 的危险因素和基因组关系
与 AMR 相关的基因位点,假设最近使用抗生素是 AMR 的危险因素。
目标 1:(a) 确定肛门直肠、咽部和泌尿生殖道沙眼衣原体和奈瑟菌的分布。
越南河内 MSM 和跨性别女性 PrEP 使用者 (n=1,300) 的淋病感染和 (b)
评估快速三站点测试的可接受性和可行性,包括支付意愿。
目标 2:(a) 收集、培养淋病奈瑟菌和口咽奈瑟菌并进行抗生素敏感性测试
奈瑟菌属物种,用于调查 AMR 的流行率和相关性,以及 b) 进行全基因组分析
对从同一个体内分离出的成对淋病奈瑟菌和奈瑟菌进行测序
研究与淋病奈瑟菌耐药性相关的基因内的关系。
这个为期两年的项目分为四个阶段,第一阶段将持续三个月,并将涉及研究进展。
第二阶段将持续一年,并将评估 C 的可接受性和可行性。
沙眼衣原体和淋病奈瑟菌筛查将持续 9 个月,并将涉及抗菌药物。
敏感性测试和全基因组测序将持续 3 个月,并将涉及传播。
通过手稿、演示以及与当地政府和卫生机构共享数据来了解调查结果。
该研究的结果将为未来 R01 提案奠定基础,以调查日常活动的影响
对淋病奈瑟菌耐药性发展的性传播感染进行筛查和治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey David Klausner其他文献
Jeffrey David Klausner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey David Klausner', 18)}}的其他基金
Pilot study of linezolid for early syphilis treatment
利奈唑胺治疗早期梅毒的初步研究
- 批准号:
10575509 - 财政年份:2022
- 资助金额:
$ 16.19万 - 项目类别:
Evaluating STI screening and antimicrobial resistance in Neisseria gonorrhoeae among PrEP users in Vietnam
评估越南 PrEP 使用者中性传播感染筛查和淋病奈瑟菌耐药性
- 批准号:
10389089 - 财政年份:2021
- 资助金额:
$ 16.19万 - 项目类别:
The diagnosis and treatment of Chlamydia trachomatis and Neisseria gonorrhoeae in pregnant women to prevent adverse neonatal consequences
孕妇沙眼衣原体和淋病奈瑟菌的诊断和治疗,防止新生儿不良后果
- 批准号:
10393464 - 财政年份:2020
- 资助金额:
$ 16.19万 - 项目类别:
Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes
性传播感染筛查预防不良分娩和新生儿结局的临床研究
- 批准号:
10385627 - 财政年份:2020
- 资助金额:
$ 16.19万 - 项目类别:
Clinical study of STI screening to prevent adverse birth and newborn outcomes
性传播感染筛查预防不良分娩和新生儿结局的临床研究
- 批准号:
10082426 - 财政年份:2020
- 资助金额:
$ 16.19万 - 项目类别:
Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis
比较头孢克肟与青霉素 G 治疗早期梅毒疗效的临床试验
- 批准号:
10652990 - 财政年份:2020
- 资助金额:
$ 16.19万 - 项目类别:
Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis
比较头孢克肟与青霉素 G 治疗早期梅毒疗效的临床试验
- 批准号:
10417271 - 财政年份:2020
- 资助金额:
$ 16.19万 - 项目类别:
Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis
比较头孢克肟与青霉素 G 治疗早期梅毒疗效的临床试验
- 批准号:
10392825 - 财政年份:2020
- 资助金额:
$ 16.19万 - 项目类别:
Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes
性传播感染筛查预防不良分娩和新生儿结局的临床研究
- 批准号:
10555240 - 财政年份:2020
- 资助金额:
$ 16.19万 - 项目类别:
Clinical trial comparing the effectiveness of cefixime versus penicillin G for treatment of early syphilis
比较头孢克肟与青霉素 G 治疗早期梅毒有效性的临床试验
- 批准号:
10079905 - 财政年份:2020
- 资助金额:
$ 16.19万 - 项目类别:
相似国自然基金
社会网络关系对公司现金持有决策影响——基于共御风险的作用机制研究
- 批准号:72302067
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高尿酸调控TXNIP驱动糖代谢重编程影响巨噬细胞功能
- 批准号:82370895
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
倒装芯片超声键合微界面结构演变机理与影响规律
- 批准号:52305599
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
寒地城市学区建成环境对学龄儿童心理健康的影响机制与规划干预路径研究
- 批准号:52378051
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
原位研究聚变燃料纯化用Pd-Ag合金中Ag对辐照缺陷演化行为的影响及其相互作用机制
- 批准号:12305308
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Effects of PrEP Drugs on Female Genital HIV Infection and Women's Reproductive Health
PrEP药物对女性生殖器HIV感染及妇女生殖健康的影响
- 批准号:
10548694 - 财政年份:2022
- 资助金额:
$ 16.19万 - 项目类别:
Effects of PrEP Drugs on Female Genital HIV Infection and Women's Reproductive Health
PrEP药物对女性生殖器HIV感染及妇女生殖健康的影响
- 批准号:
10703238 - 财政年份:2022
- 资助金额:
$ 16.19万 - 项目类别:
Evaluating STI screening and antimicrobial resistance in Neisseria gonorrhoeae among PrEP users in Vietnam
评估越南 PrEP 使用者中性传播感染筛查和淋病奈瑟菌耐药性
- 批准号:
10389089 - 财政年份:2021
- 资助金额:
$ 16.19万 - 项目类别:
Improving Efficacy of Voice Therapy Concepts via Telepractice and Mobile App Technology
通过远程治疗和移动应用技术提高语音治疗概念的功效
- 批准号:
10342353 - 财政年份:2021
- 资助金额:
$ 16.19万 - 项目类别:
Novel role of inflammasome activation in ART neurotoxicity
炎症小体激活在 ART 神经毒性中的新作用
- 批准号:
9925422 - 财政年份:2020
- 资助金额:
$ 16.19万 - 项目类别: